{"schema_version":"secwatch.filing_event.v1","accession":"0001999371-25-006011","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.275469+00:00","generated_at":"2026-05-21T08:18:20.948655+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Tonix Pharmaceuticals appoints Joseph Hand as General Counsel and EVP of Operations","bullets":["Joseph Hand appointed General Counsel and EVP of Operations, effective May 14, 2025.","Hand brings over 20 years biopharma experience; served on Celgene's Executive Committee for nearly a decade.","Played key roles in Celgene's $74B acquisition by BMS and $13.4B divestiture of Otezla to Amgen.","Appointment comes as Tonix prepares for potential FDA approval of TNX-102 SL for fibromyalgia by August 15, 2025.","Hand previously served as Chief Administrative Officer at Phathom Pharmaceuticals."],"urls":{"canonical":"https://secwatch.observer/filing/0001999371-25-006011","json":"https://secwatch.observer/filing/0001999371-25-006011.json","markdown":"https://secwatch.observer/filing/0001999371-25-006011.md","text":"https://secwatch.observer/filing/0001999371-25-006011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125006011/0001999371-25-006011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125006011/tnxp-8k_051425.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T08:18:20.948655+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}